NVAX JPM Corporate Presentation January 2026.pdf

《NVAX JPM Corporate Presentation January 2026.pdf》由会员分享，可在线阅读，更多相关《NVAX JPM Corporate Presentation January 2026.pdf（15页珍藏版）》请在三个皮匠报告上搜索。

1、 2026 NOVAVAX.All rights reserved.1Novavax Corporate PresentationJohn C.Jacobs,President and Chief Executive OfficerJ.P.Morgan Healthcare Conference 2026 NOVAVAX.All rights reserved.1 2026 NOVAVAX.All rights reserved.2We envision a world where our technology is amplified to touch the lives of billio

2、ns,sparking transformation in global health.This is Novavax 2026 NOVAVAX.All rights reserved.2 2026 NOVAVAX.All rights reserved.3Cautionary Note Regarding Forward-Looking StatementsThis presentation includes forward-looking statements.These forward-looking statements generally can be identified by t

3、he use of words such as“anticipate,”“expect,”“plan,”“could,”“may,”“will,”“believe,”“estimate,”“forecast,”“goal,”“project,”and other words of similar meaning.These forward-looking statements address various matters including Novavaxs corporate strategy and operating plans,objectives and prospects;its

4、 value drivers and near-term priorities;its partnerships,including expectations with respect to potential royalties,milestones,and cost reimbursement,and plans for additional potential partnering activities;its expectations regarding manufacturing capacity,timing,production and delivery for its COVI

5、D-19 vaccine;the transition of the lead responsibility for commercialization of Novavaxs COVID-19 vaccine to Sanofi beginning with the 2025-2026 vaccination season the development of Novavaxs clinical and preclinical product candidates and pipeline advancement;the conduct,timing and potential result

6、s from clinical trials and other preclinical and postmarketing studies;scope,timing and outcome of future and pending regulatory filings and actions;potential future market sizes and demand for its COVID-19 vaccine and product candidates;the conduct of our post marketing commitment(“PMC”)study reque